Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Mannkind Corp's inhaled diabetes drug Afrezza is safe and effective for some diabetes patients with either the type 1 or type 2 form of the disease, U.S. health advisers said on Tuesday in recommending its approval for sales in the United States.
The Food and Drug Administration's advisory panel, in a 13-1 vote, backed the rapid-acting insulin treatment for adults with type 1 diabetes despite lingering concerns over long-term safety and data that showed the drug did not work any better than traditional insulin.
In a 14-0 vote, it also supported Afrezza for adults with the more common type 2 form of the disease, saying the benefits of the alternative therapy over current insulin drugs were clearer.
http://www.globalpost.com/dispatch/...commend-mannkinds-inhaled-diabetes-drug-afrez
The Food and Drug Administration's advisory panel, in a 13-1 vote, backed the rapid-acting insulin treatment for adults with type 1 diabetes despite lingering concerns over long-term safety and data that showed the drug did not work any better than traditional insulin.
In a 14-0 vote, it also supported Afrezza for adults with the more common type 2 form of the disease, saying the benefits of the alternative therapy over current insulin drugs were clearer.
http://www.globalpost.com/dispatch/...commend-mannkinds-inhaled-diabetes-drug-afrez